Asio Capital LLC Raises Position in UnitedHealth Group Incorporated $UNH

Asio Capital LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 18.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,233 shares of the healthcare conglomerate’s stock after buying an additional 3,793 shares during the quarter. UnitedHealth Group comprises 1.3% of Asio Capital LLC’s holdings, making the stock its 21st largest position. Asio Capital LLC’s holdings in UnitedHealth Group were worth $8,368,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Brighton Jones LLC increased its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the last quarter. Truvestments Capital LLC boosted its holdings in shares of UnitedHealth Group by 6.9% in the 1st quarter. Truvestments Capital LLC now owns 636 shares of the healthcare conglomerate’s stock valued at $333,000 after acquiring an additional 41 shares during the last quarter. OMERS ADMINISTRATION Corp raised its holdings in shares of UnitedHealth Group by 57.3% during the first quarter. OMERS ADMINISTRATION Corp now owns 269,089 shares of the healthcare conglomerate’s stock worth $140,935,000 after purchasing an additional 97,968 shares during the last quarter. Finally, Okabena Investment Services Inc. grew its position in UnitedHealth Group by 1.4% during the 1st quarter. Okabena Investment Services Inc. now owns 4,504 shares of the healthcare conglomerate’s stock worth $2,359,000 after purchasing an additional 64 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Mizuho upped their target price on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. KeyCorp raised their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Bank of America boosted their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. TD Cowen lifted their price objective on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a report on Thursday, October 30th. Finally, UBS Group raised their target price on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Hold” and an average target price of $385.54.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $327.08 on Friday. The company has a market capitalization of $296.28 billion, a PE ratio of 17.07, a price-to-earnings-growth ratio of 2.13 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The firm’s 50-day moving average is $334.20 and its two-hundred day moving average is $318.80. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same period in the prior year, the business posted $7.15 earnings per share. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.